Nieuwenhuyzen-de Boer, G. M. https://orcid.org/0000-0001-7074-6201
Hofhuis, W.
Reesink-Peters, N.
Ewing-Graham, P. C.
Schoots, I. G.
Beltman, J. J.
Piek, J. M. J.
Baalbergen, A.
Kooi, G. S.
van Haaften, A.
van Huisseling, H.
Haans, L.
Dorman, M.
van Beekhuizen, H. J.
Funding for this research was provided by:
ZonMw (843001805)
Article History
Received: 13 October 2018
Accepted: 3 January 2019
First Online: 14 January 2019
Ethics approval and consent to participate
: The study will be carried out according to the standards outlined in the Declaration of Helsinki. Ethics committee approval has been granted. All procedures involving patients have been approved by the Medical Ethical Committee of Erasmus Medical Centre Rotterdam in the Netherlands (trial protocol version 3.0 d.d. 20th November 2017, NL62035.078.17).Patients from the following Dutch hospitals may be included: Albert Schweitzer (Dordrecht), Bravis (Bergen op Zoom), Catharina Cancer Institute (Eindhoven), Erasmus MC (Rotterdam), Franciscus Gasthuis and Vlietland (Rotterdam), Groene Hart Hospital (Gouda), Haags Medisch Centrum (Den Haag), Haga Hospital (Den Haag), Leids University MC (Leiden), Medisch Spectrum Twente (Enschede), Reinier de Graaf Groep (Delft).Patients will receive verbal and written information from their gynaecologist during the intake for surgery. Informed consent will be obtained from all participants to use the data for analyses. Randomization happens after signing of the Informed Consent.All data will be anonymously processed. Participants will be able to resign at any time without statement of reasons.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.